• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用自动化机器学习通过常规实验室指标预测前列腺癌

Prediction of Prostate Cancer From Routine Laboratory Markers With Automated Machine Learning.

作者信息

Satır Atilla, Üstündağ Yasemin, Yeşil Meryem Rümeysa, Huysal Kağan

机构信息

Department of Urology, University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.

Department of Medical Biochemistry, University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.

出版信息

J Clin Lab Anal. 2025 Feb;39(3):e25143. doi: 10.1002/jcla.25143. Epub 2025 Jan 19.

DOI:10.1002/jcla.25143
PMID:39828871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11821719/
Abstract

BACKGROUND

In this study, we attempted to select the optimum cases for a prostate biopsy based on routine laboratory test results in addition to prostate-specific antigen (PSA) blood test using H2O automated machine learning (AutoML) software, which includes many common machine learning algorithms.

METHODS

The study included 737 patients (46-88 years old). Routine laboratory measurements were used to train machine learning models using H2O AutoML. We created a model that classifies prostate biopsy results as malignant or benign. The performance of the best model was evaluated using the area under the receiver operating characteristic curve (AUC), log-loss metric, F1 score, positive predictive value (PPV), negative predictive value (NPV), sensitivity, and specificity. The model's performance was evaluated through the SHapley Additive exPlanations (SHAP) analysis feature-based interpretation method applied to comprehend the machine learning model.

RESULTS

The gradient boosting machine model was the most successful. The best result was obtained in the model with 11 parameters, including PSA, free PSA, free PSA to PSA, hemoglobin, neutrophils, platelets, neutrophil-to-lymphocyte ratio (NLR), glucose, platelet-to-lymphocyte ratio (PLR), lymphocytes, and age. The AUC of this model was 0.72, the specificity was 0.84, the PPV was 0.65, the NPV was 0.69, and the accuracy was 0.68.

CONCLUSION

Our results suggest that adding only routine laboratory parameters to the PSA test and developing machine learning algorithms can help reduce the number of unnecessary prostate biopsies without overlooking the diagnosis of PCa.

摘要

背景

在本研究中,我们尝试使用包含许多常见机器学习算法的H2O自动化机器学习(AutoML)软件,除前列腺特异性抗原(PSA)血液检测外,根据常规实验室检测结果选择前列腺活检的最佳病例。

方法

该研究纳入了737例患者(年龄46 - 88岁)。使用常规实验室测量数据通过H2O AutoML训练机器学习模型。我们创建了一个将前列腺活检结果分类为恶性或良性的模型。使用受试者操作特征曲线下面积(AUC)、对数损失度量、F1分数、阳性预测值(PPV)、阴性预测值(NPV)、敏感性和特异性来评估最佳模型的性能。通过应用SHapley加性解释(SHAP)分析基于特征的解释方法来评估模型性能,以理解机器学习模型。

结果

梯度提升机模型最为成功。在包含PSA、游离PSA、游离PSA与PSA比值、血红蛋白、中性粒细胞、血小板、中性粒细胞与淋巴细胞比值(NLR)、葡萄糖、血小板与淋巴细胞比值(PLR)、淋巴细胞和年龄这11个参数的模型中获得了最佳结果。该模型的AUC为0.72,特异性为0.84,PPV为0.65,NPV为0.69,准确率为0.68。

结论

我们的结果表明,在PSA检测中仅添加常规实验室参数并开发机器学习算法有助于减少不必要的前列腺活检数量,同时不会忽视前列腺癌的诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1225/11821719/4be76c9e0d75/JCLA-39-e25143-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1225/11821719/4be76c9e0d75/JCLA-39-e25143-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1225/11821719/4be76c9e0d75/JCLA-39-e25143-g002.jpg

相似文献

1
Prediction of Prostate Cancer From Routine Laboratory Markers With Automated Machine Learning.利用自动化机器学习通过常规实验室指标预测前列腺癌
J Clin Lab Anal. 2025 Feb;39(3):e25143. doi: 10.1002/jcla.25143. Epub 2025 Jan 19.
2
Role of Neutrophil to Lymphocyte Ratio or Platelet to Lymphocyte Ratio in Prediction of Bone Metastasis of Prostate Cancer.中性粒细胞与淋巴细胞比值或血小板与淋巴细胞比值在预测前列腺癌骨转移中的作用。
Clin Lab. 2019 May 1;65(5). doi: 10.7754/Clin.Lab.2018.181040.
3
Predicting Positive Repeat Prostate Biopsy Outcomes: Comparison of Machine Learning Approaches to Identify Key Parameters and Optimal Algorithms.预测前列腺重复活检阳性结果:比较机器学习方法以识别关键参数和优化算法
Arch Esp Urol. 2023 Sep;76(7):494-503. doi: 10.56434/j.arch.esp.urol.20237607.61.
4
Using XBGoost, an interpretable machine learning model, for diagnosing prostate cancer in patients with PSA < 20 ng/ml based on the PSAMR indicator.基于PSAMR指标,使用可解释的机器学习模型XBGoost对前列腺特异性抗原(PSA)<20 ng/ml的患者进行前列腺癌诊断。
Sci Rep. 2025 Jan 9;15(1):1532. doi: 10.1038/s41598-025-85963-7.
5
A novel algorithm for the prediction of prostate cancer in clinically suspected patients.一种用于预测临床疑似前列腺癌患者的新算法。
Cancer Biomark. 2013;13(4):227-34. doi: 10.3233/CBM-130357.
6
A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.在首次、二次和三次重复前列腺活检中,总前列腺特异性抗原、游离前列腺特异性抗原百分比、前列腺特异性抗原速度和尿前列腺癌基因 3 的比较性能分析。
BJU Int. 2012 Jun;109(11):1627-35. doi: 10.1111/j.1464-410X.2011.10584.x. Epub 2011 Sep 21.
7
The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4-10 ng/mL.前列腺健康指数在预测前列腺特异性抗原水平为4-10 ng/mL的亚洲男性初次前列腺活检结果中的应用
Int Urol Nephrol. 2014 Apr;46(4):711-7. doi: 10.1007/s11255-013-0582-0. Epub 2013 Oct 18.
8
Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.用于预测前列腺癌的四激肽释放酶检测组合与前列腺健康指数的比较
Eur Urol. 2015 Jul;68(1):139-46. doi: 10.1016/j.eururo.2014.08.010. Epub 2014 Aug 20.
9
Navigating the gray zone: Machine learning can differentiate malignancy in PI-RADS 3 lesions.探索灰色地带:机器学习可区分PI-RADS 3类病变中的恶性肿瘤。
Urol Oncol. 2025 Mar;43(3):195.e11-195.e20. doi: 10.1016/j.urolonc.2024.09.004. Epub 2024 Sep 28.
10
Clinico-radiological characteristic-based machine learning in reducing unnecessary prostate biopsies of PI-RADS 3 lesions with dual validation.基于临床-放射学特征的机器学习在双重验证下减少 PI-RADS 3 病变前列腺活检的必要性。
Eur Radiol. 2020 Nov;30(11):6274-6284. doi: 10.1007/s00330-020-06958-8. Epub 2020 Jun 10.

引用本文的文献

1
Diagnostic Stratification of Prostate Cancer Through Blood-Based Biochemical and Inflammatory Markers.通过基于血液的生化和炎症标志物对前列腺癌进行诊断分层
Diagnostics (Basel). 2025 May 30;15(11):1385. doi: 10.3390/diagnostics15111385.

本文引用的文献

1
Practical guide to SHAP analysis: Explaining supervised machine learning model predictions in drug development.SHAP 分析实用指南:在药物研发中解释有监督机器学习模型预测。
Clin Transl Sci. 2024 Nov;17(11):e70056. doi: 10.1111/cts.70056.
2
Machine learning-based clinical decision support using laboratory data.基于机器学习的实验室数据临床决策支持。
Clin Chem Lab Med. 2023 Nov 29;62(5):793-823. doi: 10.1515/cclm-2023-1037. Print 2024 Apr 25.
3
Machine learning-based prediction model and visual interpretation for prostate cancer.
基于机器学习的前列腺癌预测模型与可视化解读
BMC Urol. 2023 Oct 14;23(1):164. doi: 10.1186/s12894-023-01316-4.
4
Stability of clinical prediction models developed using statistical or machine learning methods.基于统计或机器学习方法开发的临床预测模型的稳定性。
Biom J. 2023 Dec;65(8):e2200302. doi: 10.1002/bimj.202200302. Epub 2023 Jul 19.
5
Diagnostic Utility of NLR, PLR and MLR in Early Diagnosis of Gastric Cancer: an Analytical Cross-Sectional Study.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值和单核细胞与淋巴细胞比值对胃癌早期诊断的诊断效能:一项分析性横断面研究。
J Gastrointest Cancer. 2023 Dec;54(4):1322-1330. doi: 10.1007/s12029-023-00937-0. Epub 2023 May 18.
6
Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit.当前前列腺癌早期检测政策造成了过度诊断和不公平现象,而获益却微乎其微。
BMJ. 2023 May 17;381:e071082. doi: 10.1136/bmj-2022-071082.
7
Individual risk prediction of high grade prostate cancer based on the combination between total prostate-specific antigen (PSA) and free to total PSA ratio.基于总前列腺特异性抗原(PSA)和游离 PSA 与总 PSA 比值的联合,对高级别前列腺癌进行个体风险预测。
Clin Chem Lab Med. 2023 Jan 27;61(7):1327-1334. doi: 10.1515/cclm-2023-0008. Print 2023 Jun 27.
8
Prostate Cancer Risk Prediction and Online Calculation Based on Machine Learning Algorithm.基于机器学习算法的前列腺癌风险预测及在线计算。
Chin Med Sci J. 2022 Sep 30;37(3):210-217. doi: 10.24920/004086.
9
Machine learning model for the prediction of prostate cancer in patients with low prostate-specific antigen levels: A multicenter retrospective analysis.用于预测前列腺特异性抗原水平低的患者患前列腺癌的机器学习模型:一项多中心回顾性分析。
Front Oncol. 2022 Aug 18;12:985940. doi: 10.3389/fonc.2022.985940. eCollection 2022.
10
Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future.欧洲及全球基于血清前列腺特异性抗原的前列腺癌早期检测:过去、现在与未来
Nat Rev Urol. 2022 Sep;19(9):562-572. doi: 10.1038/s41585-022-00638-6. Epub 2022 Aug 16.